Amarin Corp Plcuk (AMRN) Total Debt (2010 - 2020)
Amarin Corp Plcuk (AMRN) reported Total Debt of $9.5 million for Q3 2020, down 84.23% year-over-year from $60.0 million in Q4 2019, and down 57.84% quarter-over-quarter from $22.5 million in Q2 2020.
Amarin Corp Plcuk (AMRN) Total Debt (2010 - 2020) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 11 years of Total Debt data on file, last reported at $9.5 million in Q3 2020.
- Total Debt for Q3 2020 came in at $9.5 million, down 84.23% year-over-year; the trailing twelve-month figure through Sep 2020 was $9.5 million (down 84.23% YoY), and the FY2019 annual result was $50.1 million, down 37.61% from the prior year.
- Total Debt retreated to $9.5 million in Q3 2020 per AMRN's latest filing, from $22.5 million in the prior quarter.
- Over five years, Total Debt peaked at $156.5 million in Q2 2016 and troughed at $9.5 million in Q3 2020.
- A 5-year average of $60.5 million and a median of $53.4 million in 2018 frame the typical range for Total Debt.
- The sharpest annual moves came in 2016 and 2019: Total Debt plunged 87.17% in 2016, then soared 131.92% in 2019.
- A 5-year view of Total Debt shows it stood at $100.5 million in 2016, then slumped by 48.92% to $51.3 million in 2017, then soared by 56.5% to $80.3 million in 2018, then sank by 37.61% to $50.1 million in 2019, then plunged by 81.12% to $9.5 million in 2020.
- Business Quant data shows AMRN's Total Debt at $9.5 million in Q3 2020, $22.5 million in Q2 2020, and $37.0 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -18.89 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 43.37 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 54.99 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 64.53 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 49.12 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 57.32 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 22.17 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 64.46 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 44.46 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 9.47 Mn |
| Jun 30, 2020 | 22.46 Mn |
| Mar 31, 2020 | 36.98 Mn |
| Dec 31, 2019 | 50.13 Mn |
| Sep 30, 2019 | 60.04 Mn |
| Jun 30, 2019 | 68.61 Mn |
| Mar 31, 2019 | 74.30 Mn |
| Dec 31, 2018 | 80.35 Mn |
| Sep 30, 2018 | 29.38 Mn |
| Jun 30, 2018 | 29.58 Mn |
| Mar 31, 2018 | 53.42 Mn |
| Dec 31, 2017 | 51.34 Mn |
| Sep 30, 2017 | 29.16 Mn |
| Jun 30, 2017 | 79.74 Mn |
| Mar 31, 2017 | 99.41 Mn |
| Dec 31, 2016 | 100.51 Mn |
| Sep 30, 2016 | 13.47 Mn |
| Jun 30, 2016 | 156.46 Mn |
| Mar 31, 2016 | 104.74 Mn |
| Dec 31, 2015 | 149.21 Mn |